Sara A. Alsalamah

Mrs. Sara A. Alsalamah

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024
Verified
Conference Paper
Open access
PDF file
MAMariam ALMutairi
Mariam ALMutairi
LALulwah AlKulaib
Lulwah AlKulaib
MAMelike Aktas
Melike Aktas
SASara A. Alsalamah
Sara A. Alsalamah
CLChang-Tien Lu
Chang-Tien Lu
Mariam ALMutairi, Lulwah AlKulaib, Melike Aktas, Sara Alsalamah, Chang-Tien Lu. Proceedings of The Second Arabic Natural Language Processing Conference. 2024.

17 June 2025 in Network Modeling Analysis in Health Informatics and Bioinformatics
Verified
Journal Article
Open access
PDF file
SASara A. Alsalamah
Sara A. Alsalamah
SAShada Alsalamah
Shada Alsalamah
HAHessah Alsalamah
Hessah Alsalamah
HSHaytham Sheerah
Haytham Sheerah
KLKurt Luther
Kurt Luther
CLChang-Tien Lu
Chang-Tien Lu
This study addresses the growing role of Virtual Healthcare (VHC) in mitigating the global shortage of skilled healthcare workers and explores how Artificial Intelligence (AI) can empower clinicians by providing rapid, reliable information at the point of care. However, the proliferation of AI in healthcare poses risks of potential deskilling of clinicians’ judgment and the inability of some non-AI platforms to deliver Person-Centered (PC) care. These shortcomings may lead to unsafe self-diagnosis practices. This paper introduces VHC-Bot, an AI-driven PC VHC platform designed to strike a balance between patient autonomy, healthcare worker expertise, and AI support to deliver accurate, efficient, and personalized care. It emphasizes collaborative decision-making, effective communication, and knowledge-sharing to enhance clinical skills. The study leverages advanced AI models to design the VHC-Bot platform and integrates PC care principles. Key components include natural language processing for effective communication, diagnostic algorithms for precise symptom evaluation, and machine learning models to adapt to individual patient needs. Performance evaluation methods include clinical simulation testing, patient satisfaction surveys, and workflow efficiency analysis. Results indicate significant improvements in diagnostic accuracy, consultation times, and clinician-patient communication using the platform, which fosters collaboration among healthcare professionals, enhancing their clinical judgment and maintaining decision-making authority. Furthermore, patient satisfaction scores demonstrated marked improvement due to the personalized and accessible care provided by VHC-Bot. VHC-Bot delivers high-quality, efficient care while safeguarding human expertise in clinical judgment. This approach ensures accessible healthcare, efficient, and human-centred, setting a benchmark for future AI-integrated VHC systems.

22 June 2025 in Electronics
Verified
Journal Article
Open access
PDF file
SAShada Alsalamah
Shada Alsalamah
SAShaima A. Alnehmi
Shaima A. Alnehmi
AAAnfal A. Abanumai
Anfal A. Abanumai
AAAsmaa H. Alnashri
Asmaa H. Alnashri
SASara S. Alduhim
Sara S. Alduhim
HAHessah Alsalamah
Hessah Alsalamah
The coronavirus pandemic has spread globally, affecting over 700 million people and resulting in over 7 million deaths. In response, global pharmaceutical companies and disease control centers have urgently sought effective treatments and vaccines. However, the rise of counterfeit drugs has become a significant concern amid this urgency. To standardize the legal provision and usage of genetic resources, the United Nations Development Program (UNDP) introduced the Nagoya Protocol. Despite advancements in drug research, the production process remains tedious, complex and vulnerable to fraud. FairChain addresses this pressing challenge by creating a transparent ecosystem that builds trust among all stakeholders throughout the Drug Development Life Cycle (DDLC) by using decentralized, immutable, and transparent blockchain technology. This makes FairChain the first digital health tool to implement the principles of the UNDP’s Nagoya Protocol among all stakeholders throughout all DDLC stages, starting with sample collection, to discovery and development, to preclinical research, to clinical development, to regulator review, and ending with post-market monitoring. Therefore, FairChain allows pharmaceutical companies to document the entire drug production process, landowners to monitor bio-samples from their land, doctors to share clinical research, and regulatory agencies such as the Food and Drug Authority to oversee samples and authorize production. FairChain should enhance transparency, foster trust and efficiency, and ensure a fair and traceable DDLC. To date, no blockchain-based framework has addressed the integration of traceability, auditability, and Nagoya Protocol compliance within a unified system architecture. This paper introduces FairChain, a system that formalizes these requirements in a modular, policy-aligned, and verifiable digital trust infrastructure.

2 September 2026 in Frontiers in Digital Health
Verified
Journal Article
Open access
PDF file
SASara A. Alsalamah
Sara A. Alsalamah
AAAlbatoul Althenayan
Albatoul Althenayan
MAMariam Almutairi
Mariam Almutairi
SAShada AlSalamah
Shada AlSalamah
HAHessah A. Alsalamah
Hessah A. Alsalamah
CLChang-Tien Lu
Chang-Tien Lu
Introduction: Virtual hospital systems support remote triage and diagnosis across distributed healthcare environments by integrating radiographic imaging with structured clinical information for clinical decision making. However, many existing diagnostic frameworks do not fully address real world challenges commonly encountered in scalable virtual healthcare settings. These challenges include severe class imbalance, incomplete clinical attributes, heterogeneous multimodal inputs, and variability in data quality across institutions. Methods: This study introduces VHealth-MFusion , a fusion-based hierarchical multimodal deep learning framework that integrates chest X-ray (CXR) imaging and structured clinical data within a unified convolutional neural network (CNN) and multilayer perceptron (MLP) architecture. Using pneumonia Tele-Diagnosis as a use case, the proposed framework combines radiographic feature extraction through a CNN branch with structured clinical representation learning through an MLP branch, followed by late multimodal fusion for multiclass respiratory disease classification. The framework was evaluated using a hierarchical multimodal dataset containing CXR images across multiple diagnostic categories, including Normal, Bacterial, Adenovirus, Influenza, MERS-CoV, and SARS-CoV-2, together with 632 structured clinical variables comprising demographic information, vital signs, symptoms, and laboratory findings. Results: Under a controlled dataset-consistent comparison against an established hierarchical multimodal CNN baseline, VHealth-MFusion achieved 97.2% classification accuracy, outperforming the baseline accuracy of 95.9%. Discussion: The findings demonstrate that multimodal integration of radiographic imaging and structured clinical information can improve diagnostic robustness and support more reliable Tele-Diagnosis workflows within virtual hospital environments. Overall, the proposed framework contributes a practically oriented multimodal diagnostic architecture designed to facilitate scalable remote clinical services and informed decision making within digitally enabled care systems where imaging and structured clinical information are jointly available.

6 November 2026
Verified
Conference Paper
Open access
MAMariam Almutairi
Mariam Almutairi
FAFatimah D. Alotaibi
Fatimah D. Alotaibi
LALulwah Alkulaib
Lulwah Alkulaib
Zhiqian ChenZhiqian Chen
Zhiqian Chen
SASara A. Alsalamah
Sara A. Alsalamah
CLChang-Tien Lu
Chang-Tien Lu
Knowledge-graph-based retrieval-augmented generation (KG-RAG) grounds large language model (LLM) outputs in structured facts by retrieving a query-relevant subgraph before generation. However, existing KG-RAG systems often assume that the retrieved graph contains sufficient evidence to answer the query. When this assumption fails, the LLM may produce an answer that is factually plausible but not faithfully grounded in the KG. To address this problem, we introduce Query-Graph Compatibility (QGC), a formal, model-independent pre-condition for faithful KG-grounded generation. Given a natural-language query parsed into a typed conjunctive query and a KG with schema, QGC checks whether the query has a valid typed match in the graph, formalized as a typed homomorphism. If QGC=0, the KG lacks the structural evidence required by the query, so no generation model, regardless of architecture or scale, can produce a faithful answer from the KG alone-a consequence that follows directly from our definitions but yields a checkable pre-generation condition. QGC inherits the classical complexity of conjunctive-query evaluation: NP-complete in general, yet tractable for the bounded-width query structures that cover all KGQA queries in our evaluation. We validate QGC across six datasets and four domains. Under controlled edge deletion on MetaQA, QGC predicts LLM failure with AUC 0.78-0.93 for 1-2 hop queries across five LLMs, with accuracy gaps of +55 to +86 percentage points. Under natural incompleteness in clinical KGs (MIMIC-III, CORAL), all five evaluated models show positive QGC accuracy gaps (+5 to +31 percentage points), while PrimeKGQA exposes a boundary condition: structurally simpler QGC=0 contexts can yield higher correctness despite lacking faithful grounding. QGC checking runs in under 0.1 ms per query, making it practical as a real-time pre-filter or retrieval stopping criterion.